Latest filing published 17 Mar 2016 for ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/, €957.
Insider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +2.4%Entry US$4.08 · Close at T+365 US$4.18
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Derek Thomas Welch: trading record in brief
Derek Thomas Welch is a declared insider of Arrhythmia Research Technology Inc /DE/, with filings sourced from SEC (Form 4). In total, 3 filings cover trades dated from 17 December 2015 to 16 March 2016.
No open-market sale appears; the market trades are 2 purchases worth €1,325. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 1 share grant. So far in 2016, the count stands at 2 purchases and no sales.
The newest entry dates from 17 March 2016: an open-market purchase of €957, in Arrhythmia Research Technology Inc /DE/. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Derek Thomas Welch
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 260 shares@ US$4.0972.2% of flowCommon StockSEC:0000819689-16-000097:0Canonical exit: 14 Jun 2016 (T+90)
- 100 shares@ US$4.0927.8% of flowCommon StockSEC:0000819689-16-000097:1Canonical exit: 14 Jun 2016 (T+90)
- 1,450 shares@ US$5.48Common StockSEC:0000819689-15-000075:0
3 of 3 declarations